US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.62

+0.04000.11%

Post-market: 36.620.0040+0.01%19:30 EDT

Volume:92.44K

Turnover:3.38M

Market Cap:864.23M

PE:- -

High:36.69

Open:36.67

Low:36.48

Close:36.58

52wk High:38.19

52wk Low:29.46

Shares:23.60M

Float Shares:23.60M

Volume Ratio:0.28

T/O Rate:0.39%

Dividend:0.22

Dividend Rate:0.61%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Revvity to acquire Human Cell Design

Actinogen Medical Expands ASX-Quoted Share Base

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan

Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options

China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily

Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids

Medical Device Inspection Campaign Launched by Ningyang County Market Regulators

MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential

Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong

Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period

Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

Citizens biotechnology analyst holds analyst/industry conference call

Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects

Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/RSPH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.62,"timestamp":1790971200000,"preClose":36.58,"halted":0,"volume":92444,"hourTrading":{"tag":"盘后","latestPrice":36.624,"preClose":36.62,"latestTime":"19:30 EDT","volume":1184,"amount":43358.247,"timestamp":1790983803967,"change":0.004,"changeRate":0.000109,"amplitude":0.000625},"delay":0,"changeRate":0.0010934937124111304,"floatShares":23600000,"shares":23600000,"eps":0,"marketStatus":"Market Closed","change":0.04,"latestTime":"10-02 16:00:00 EDT","open":36.67,"high":36.69,"low":36.48,"amount":3382656.121152,"amplitude":0.005741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":36.58,"sharesOutstanding":23410000,"nav":36.58584,"aum":874515507.41,"dividendRate":0.006065,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.61,"preClose":36.58,"latestTime":"08:05 EDT","volume":2,"amount":73.19,"timestamp":1790942720925,"change":0.03,"changeRate":0.00082,"amplitude":0.00082},"postHourTrading":{"tag":"盘后","latestPrice":36.624,"preClose":36.62,"latestTime":"19:30 EDT","volume":1184,"amount":43358.247,"timestamp":1790983803967,"change":0.004,"changeRate":0.000109,"amplitude":0.000625},"volumeRatio":0.2809779702771862,"impliedVol":0.0046,"impliedVolPercentile":0.0598},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23600000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2809779702771862,"shares":23600000,"dividePrice":0.2221,"high":36.69,"amplitude":0.005741,"preClose":36.58,"low":36.48,"week52Low":29.46,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.62,"eps":0,"divideRate":0.006065,"volume":92444,"delay":0,"ttmEps":0,"open":36.67,"prevYearClose":31.85,"prevWeekClose":37.36,"prevMonthClose":37.01,"prevQuarterClose":37.01,"fiveDayClose":37.36,"twentyDayClose":37.87,"sixtyDayClose":34.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"RSPH","amount":0.05159,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666458412","title":"Revvity to acquire Human Cell Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458412","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458412?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:05","pubTimestamp":1788948328,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced it has entered into a definitive agreement to acquire Human Cell Design, or HCD, a France-based biotechnology company spec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","IEIH","FHLC","BK4585","IE00BLDYK493.USD","BK4588","XT","SYNB","RSPH","BBP","BK4121","IE00BN0W2V16.EUR","DARP","FWD","RVTY","IE00B64QTZ34.USD","LNGR","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IBB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666301843","title":"Actinogen Medical Expands ASX-Quoted Share Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2666301843","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666301843?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:52","pubTimestamp":1788922334,"startTime":"0","endTime":"0","summary":"An announcement from Actinogen Medical ( ($AU:ACW) ) is now available. Actinogen Medical Limited, a biotechnology company listed on the ASX under t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-expands-asx-quoted-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BK4585","FWD","BK4588","XT","LNGR","JDOC","SYNB","IEIH","FHLC","RSPH","IBB","BBP","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FXH","WDNA","JDOC","SBIO","BBH","GSKH","NVIB","MNTL","AZNH","LFSC","HRTS","GNOM","LLYX","IBRN","MEDI","PBPH","GNMX","MDTX","BBP","IBB","MEDX","GDOC","GPCR","PJP","BME","BIB","CANC","FBT","CURE","FHLC","TBXU","IBBQ","PTH","IEIH","IDNA","RSPH","XPH","JHMH","FTXH","CNCR","APXH","PSCH","IBBJ","SURI","PINK","SYNB","HYLG","PBE","PSIL","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","GSKH","FHLC","IBBQ","APXH","PSCH","HYLG","SURI","PSIL","GPCR","FTXH","LENZ","BBP","CURE","RSPH","PBPH","TBXU","AZNH","BIB","MEDI","GDOC","MEDX","BBH","IBB","NVIB","JHMH","LLYX","IBBJ","FBT","GNOM","HRTS","SYNB","JDOC","XPH","PINK","MNTL","MDTX","FXH","SBIO","LFSC","BME","PTH","PJP","CANC","WDNA","IBRN","GNMX","PBE","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665340152","title":"CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340152?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:53","pubTimestamp":1788850386,"startTime":"0","endTime":"0","summary":"CSL ( ($AU:CSL) ) has provided an announcement. CSL Limited is a global biotechnology company that develops and supplies vaccines, plasma-derived t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","PBPH","XT","RSPH","BK4588","AGNG","BK4585","FWD","JDOC","FHLC","IEIH","IBB","SYNB","DARP","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344433","title":"Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 12:37","pubTimestamp":1788842272,"startTime":"0","endTime":"0","summary":"Opthea ( ($AU:CYV) ) just unveiled an update. Ceryvyn Therapeutics Limited, an ASX-listed biotechnology company trading under the code CYV, develop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","BK4585","FWD","BK4139","BK4007","BK4588","XT","BK4539","LNGR","JDOC","SYNB","IEIH","FHLC","LENZ","RSPH","IBB","BBP","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106413707","title":"China Securities Reports Medical Device Sector Sustains Earnings Improvement While Medical Services Revenue Grows Steadily","url":"https://stock-news.laohu8.com/highlight/detail?id=1106413707","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106413707?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:34","pubTimestamp":1788838468,"startTime":"0","endTime":"0","summary":"China Securities has released a research note indicating that the medical device sector maintained its revenue growth trajectory in Q2, with quarterly profit growth turning positive for the first...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","AGNG","LGHT","PTH","MEDX","HART","BK1100","IEIH","GDOC","LNGR","BK0276","09996","BK1574","MDEV","159883","601066","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185411766","title":"Novo Nordisk's GLP-1 Drug Shows Promise in Reducing Childhood Obesity in Younger Kids","url":"https://stock-news.laohu8.com/highlight/detail?id=1185411766","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185411766?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:20","pubTimestamp":1788783624,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO.US) announced on Monday that in a late-stage clinical trial, its blockbuster weight-loss drug Wegovy's active ingredient, semaglutide, helped 40.4% of children aged 6 to under 12...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURE","PINK","RSPH","NBDS","NVOX","FHLC","IYH","NVOH","XLVI","PJP","BGIA","THNR","TRUH","FXH","NVOC","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155170383","title":"Medical Device Inspection Campaign Launched by Ningyang County Market Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1155170383","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155170383?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:41","pubTimestamp":1788756073,"startTime":"0","endTime":"0","summary":"On September 7, enforcement officers from the Market Supervision Administration of Ningyang County, Shandong Province, visited retail pharmacies within their jurisdiction to conduct a targeted...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","LGHT","MEDX","LNGR","GDOC","HART","09996","BK1100","159883","BK1583","IEIH","BK1574","PTH","MDEV","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191894169","title":"MedTech Firm Joins Hong Kong Market: Evaluating MEDCAPTAIN's (02041) True Investment Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1191894169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191894169?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754720,"startTime":"0","endTime":"0","summary":"As a wave of interim earnings reports floods in from medical device companies, the sector's recovery trajectory has become increasingly clear, with a definitive upward inflection point now visible in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","02041","IEIH","GDOC","AGNG","VXUS","MDEV","BK4588","PTH","BK1583","LNGR","BK4585","HART","LGHT","159883","RSPH","KCAI","BK1100","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396581","title":"Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396581?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:12","pubTimestamp":1788750740,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Qurient Co., Ltd. ( ($KR:115180) ). Qurient Co., Ltd., a Korea-based biotechnology company, is seeking to raise...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FWD","FHLC","DARP","IBB","IEIH","AGNG","BK4585","STmain","JDOC","LNGR","RSPH","SYNB","XT","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121796426","title":"Brain-Computer Interface Startups Must Walk the Line Between Vast Potential and Near-Term Medical Reality, Says Formatia Founder","url":"https://stock-news.laohu8.com/highlight/detail?id=1121796426","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121796426?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:10","pubTimestamp":1788588618,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held September 4-6 in Chengdu, Sichuan, under the theme \"Enterprise Innovation and Cycle Crossing,\" Formatia Founder and CEO Peng Lei offered a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159883","MDEV","IEIH","PTH","RSPH","BK1100","LGHT","MNTL","MEDX","HART","09996","BK1583","LNGR","AGNG","GDOC","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LU0889565916.HKD","LFSC","LU0320765992.SGD","BBP","SYNB","TECB","EKG","PINK","BMED","BK4551","BK4585","IBB","BK4535","GH","PSCH","XLVX","PTH","BK4588","IDNA","LU0109394709.USD","MEDI","GDOC","IYH","NVIB","GNMX","FRTY","FFOX","MRNX","HELX","LABU","TBXU","MRNY","RSPH","GNOM","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665355353","title":"AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665355353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665355353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:46","pubTimestamp":1788540418,"startTime":"0","endTime":"0","summary":"AcroMeta Group Limited ( ($SG:43F) ) just unveiled an announcement. AcroMeta Group Limited has signed a non-binding term sheet with biotechnology f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","DARP","BK4209","FWD","XT","BK4585","IEIH","SG","BBP","LNGR","AGNG","SYNB","FHLC","IBB","BK4588","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664928878","title":"SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2664928878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664928878?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:15","pubTimestamp":1788426920,"startTime":"0","endTime":"0","summary":"SD Biotechnologies Co., Ltd. ( ($KR:217480) ) has issued an update. SD Biotechnologies Co., Ltd., a KOSDAQ-listed biotechnology company, is under r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FWD","FHLC","DARP","IBB","IEIH","AGNG","BK4585","JDOC","LNGR","RSPH","SYNB","XT","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121486923","title":"Yinchuan Market Regulators Roll Out Comprehensive Measures to Implement Revised Medical Device Production Quality Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=1121486923","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121486923?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:00","pubTimestamp":1788422444,"startTime":"0","endTime":"0","summary":"The Yinchuan Municipal Market Supervision Administration in Ningxia is advancing a multi-pronged strategy to ensure the smooth implementation of the newly revised Medical Device Production Quality...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","MEDX","BK1574","LNGR","MDEV","159883","09996","LGHT","BK1583","HART","PTH","IEIH","AGNG","BK1100","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214842","title":"Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214842","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664214842?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:47","pubTimestamp":1788392845,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics, a clinical-stage biotechnology company developing disease-modify...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","IEIH","XBI","XLV","BK4581","AGNG","LU0029874061.USD","RSPH","BBC","HCSG","BK4588","BBP","BK4585","XT","FHLC","BK4137","BK4539","BK4007","SYNB","FWD","LABU","LU0128526141.USD","BK4139","JDOC","LNGR","DARP","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843934","title":"Citizens biotechnology analyst holds analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843934","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843934?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:45","pubTimestamp":1788367511,"startTime":"0","endTime":"0","summary":"Analysts discuss showcasing Twilio’s (TWLO) SIGNAL highlights on an Analyst/Industry conference call to be held on September 4. Published first on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4528","BK4588","LU0949170772.SGD","AGNG","LU0205194284.USD","IBB","BK4548","LU0205193047.USD","LU0345770993.USD","LU0345770308.USD","SYNB","LU1668664300.SGD","BK4585","LU1548497426.USD","LU0106831901.USD","FHLC","LU2357305700.SGD","CLOU","BK4608","LNGR","LU1791807156.HKD","LU0661504455.SGD","TWLO","BK4551","JDOC","LU0012050646.USD","CFG","LU0738911758.USD","BK4116","LU1861558580.USD","LU1720051017.SGD","LU0106261612.USD","FWD","XT","BK4613","IEIH","LU1720051108.HKD","LU1861559042.SGD","IAT","BK4211","LU2237438978.USD","BBP","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149967319","title":"Shenzhen Regulator Launches 2026 Roadshow Selection for Key Medical Device Innovation Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=1149967319","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149967319?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:44","pubTimestamp":1788349448,"startTime":"0","endTime":"0","summary":"To advance high-quality development in the medical device industry and uncover promising local innovations, the Shenzhen Municipal Market Supervision Administration recently organized a roadshow and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1583","GDOC","HART","AGNG","PTH","LNGR","LGHT","MDEV","RSPH","BK1100","159883","BK1574","IEIH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186287506","title":"Shinva Medical Secures Class II and III Device Approvals for Advanced Radiotherapy and Thoracoscopic Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=1186287506","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186287506?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:51","pubTimestamp":1788335497,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co.,Ltd. (600587.SH) has announced that it recently received the Medical Device Registration Certificate from China's National Medical Products Administration, while its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","LGHT","BK1583","BK0028","HART","LNGR","BK1100","BK0188","BK1574","GDOC","IEIH","MEDX","PTH","09996","RSPH","159883","MDEV","BK0251","600587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}